Bio Key International Inc (BKYI) stock
Close on Nov 11, 2026Market cap $3.56MP/E –Yield –
Bio Key International Inc saw revenue fall 3.1% to $6.70M over the twelve months to Jun 30, 2026. Free cash flow was -$4.16M. At the latest close the market valued the company at $3.56M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.56M
- P/E ratio
- –
- Price to sales
- 0.53
- Price to book
- 0.82
- Dividend yield
- –
- Free cash flow yield
- -116.87%
Fundamentals
- Revenue
- $6.70M
- Net income
- -$6.04M
- EPS, diluted
- -$6.82
- Free cash flow
- -$4.16M
- Book value per share
- $4.18
- Diluted shares
- 1M
Trading
- Next earnings
- Nov 13, 2026 (estimated, before the open)
- Previous close
- $2.36
- Open
- $2.46
- Day's range
- $2.43 – $2.59
- Volume
- 490,105
- Average volume (20 days)
- 4,400,893
- Beta (5 years)
- 0.72
- 52-week range
- $1.55 – $11.10
- RSI (14 days)
- 49.1
- Volatility (1 year)
- 160.5%
- Relative volume
- 0.13×
- WACC
- 8.5%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BKYI | S&P 500 | Difference | BKYI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +48.5% | -2.4% | +50.9 pts | ||
| 3 months | -36.4% | -1.2% | −35.3 pts | ||
| Year to date | -54.0% | +12.3% | −66.3 pts | ||
| 1 year | -69.8% | +12.4% | −82.3 pts | ||
| 3 years | -92.4% | +78.8% | −171.2 pts | -57.6% | +21.4% |
| 5 years | -99.6% | +75.2% | −174.7 pts | -66.1% | +11.9% |
| 10 years | -99.9% | +311.1% | −411.1 pts | -53.0% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Bio Key International filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Update
- News
About Bio Key International
Services-Prepackaged Software
BIO-key International, Inc. provides identity and access management platforms, multi-factor authentication, and biometric security software. Its principal offerings include PortalGuard and PortalGuard Identity-as-a-Service for enterprise workforce and customer identity, WEB-key civil identity infrastructure, and the MobileAuth mobile authentication application. The company also produces compact fingerprint scanners and FIDO-compliant hardware, as well as software development kits and application programming interfaces that embed biometric authentication into third-party software. BIO-key serves enterprise, education, and government clients, including healthcare systems, law enforcement agencies, defense forces, and original equipment manufacturers.
Company profile, executives and historyBio Key International stock: common questions
What is Bio Key International's stock price?
BKYI closed at $2.48 on Nov 11, 2026, up 5.08% on the day. Over the past 52 weeks it traded between $1.55 and $11.10.
What is Bio Key International's market cap?
Bio Key International was worth $3.56M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BKYI's P/E ratio?
Bio Key International lost money over the twelve months to Jun 30, 2026 (diluted EPS -$6.82), so it has no meaningful P/E ratio.
How much revenue does Bio Key International make?
Bio Key International reported revenue of $6.70M for the twelve months to Jun 30, 2026, down 3.1% from a year earlier.
Does Bio Key International pay a dividend?
No. Bio Key International has not paid a cash dividend over the last twelve months.
When does Bio Key International report earnings next?
Bio Key International is expected to report Q3 FY2026 results on Nov 13, 2026, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has BKYI stock performed over the past year?
Including dividends, BKYI returned -69.8% over the past year, against +12.4% for the S&P 500.
How many BKYI shares are sold short?
0M shares were sold short at the latest FINRA report, 113.07% of the float, or 1.0 days of average trading volume.
Who are Bio Key International's competitors?
Companies most similar to Bio Key International by business, industry and size include AWRE, AUID, ROC, IDAI, ORKT.
See a number that looks wrong?